Sean McCutcheon
Stock Analyst at Raymond James
(4.29)
# 1,310
Out of 5,070 analysts
44
Total ratings
36.4%
Success rate
28.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Reiterated: Buy | $24 → $22 | $2.72 | +708.82% | 2 | Sep 9, 2026 | |
| XNCR Xencor | Rated: Buy | $40 → $46 | $24.94 | +84.44% | 2 | Sep 1, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $76 → $248 | $196.55 | +26.18% | 3 | Aug 27, 2026 | |
| BDTX Black Diamond Therapeutics | Reiterated: Buy | $11 | $2.07 | +431.40% | 3 | Aug 6, 2026 | |
| FTH Faeth Therapeutics | Initiated Coverage: Buy | $56 | $20.79 | +169.36% | 1 | Jul 31, 2026 | |
| RLAY Relay Therapeutics | Reiterated: Buy | $19 → $26 | $18.45 | +40.92% | 2 | May 19, 2026 | |
| ENGN enGene Therapeutics | Reiterated: Buy | $27 → $4 | $1.67 | +139.52% | 5 | May 8, 2026 | |
| CMPX Compass Therapeutics | Downgraded: Hold | n/a | $0.8333 | - | 3 | Apr 28, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | $12 → $19 | $10.74 | +76.91% | 4 | Feb 24, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $29 | $7.40 | n/a | 5 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $30.75 | n/a | 4 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $61.68 | n/a | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $807.48 | n/a | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $65 | $17.20 | n/a | 1 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 | $19.01 | n/a | 3 | Jun 13, 2025 |
BridgeBio Oncology Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $24 → $22
Current: $2.72
Upside: +708.82%
Xencor
Sep 1, 2026
Rated: Buy
Price Target: $40 → $46
Current: $24.94
Upside: +84.44%
Revolution Medicines
Aug 27, 2026
Reiterated: Buy
Price Target: $76 → $248
Current: $196.55
Upside: +26.18%
Black Diamond Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $11
Current: $2.07
Upside: +431.40%
Faeth Therapeutics
Jul 31, 2026
Initiated Coverage: Buy
Price Target: $56
Current: $20.79
Upside: +169.36%
Relay Therapeutics
May 19, 2026
Reiterated: Buy
Price Target: $19 → $26
Current: $18.45
Upside: +40.92%
enGene Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $27 → $4
Current: $1.67
Upside: +139.52%
Compass Therapeutics
Apr 28, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.8333
Upside: -
Vir Biotechnology
Feb 24, 2026
Reiterated: Buy
Price Target: $12 → $19
Current: $10.74
Upside: +76.91%
REGENXBIO
Sep 5, 2025
Reiterated: Buy
Price Target: $29
Current: $7.40
Upside: n/a
Jul 24, 2025
Reiterated: Hold
Price Target: n/a
Current: $30.75
Upside: n/a
Jul 17, 2025
Reiterated: Hold
Price Target: n/a
Current: $61.68
Upside: n/a
Jul 17, 2025
Reiterated: Hold
Price Target: n/a
Current: $807.48
Upside: n/a
Jul 11, 2025
Initiated Coverage: Buy
Price Target: $65
Current: $17.20
Upside: n/a
Jun 13, 2025
Reiterated: Buy
Price Target: $86
Current: $19.01
Upside: n/a